pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Preclinical
    AWAKE-101
    Pancreatic Ductal Adenocarcinoma Loki Therapeutics Inc
  • Phase 2
    AXER-204
    Chronic Spinal Cord Injury ReNetX Bio
  • AXUMIN
    AXUMIN (FLUCICLOVINE F-18)
    no indication BLUE EARTH
  • Preclinical
    AXV-102
← prev
page 59 of 231
next →
131
Pain89
Neurology1
no indication
Axovia Therapeutics Ltd
  • AZATHIOPRINE SODIUM
    AZATHIOPRINE SODIUM
    no indication HIKMA
  • Phase 2
    AZD-0120
    Refractory Multiple Myeloma Gracell Biotechnologies Inc
  • Phase 2
    AZD-0292
    Bronchiectasis$AZN ASTRAZENECA PLC
  • Phase 3
    AZD-1390
    Recurrent Glioblastoma Multiforme (GBM)$AZN ASTRAZENECA PLC
  • Phase 2
    AZD-5148
    Clostridioides difficile Infections (Clostridium difficil…$AZN ASTRAZENECA PLC
  • Phase 2
    AZD-5863
    Adenocarcinoma Of The Gastroesophageal Junction$AZN ASTRAZENECA PLC
  • Phase 2
    AZD-7760
    Staphylococcus aureus Infections$AZN ASTRAZENECA PLC
  • Phase 1
    AZD-8965
    Idiopathic Pulmonary Fibrosis$AZN ASTRAZENECA PLC
  • AZELASTINE
    AZELASTINE
    no indication ALKEM LABS LTD
  • AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
    AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
    no indication TEVA PHARMS USA INC
  • AZITHROMYCIN DIHYDRATE
    AZITHROMYCIN DIHYDRATE
    no indication STRIDES PHARMA
  • AZITHROMYCIN MONOHYDRATE
    AZITHROMYCIN MONOHYDRATE
    no indication Gland Pharma Ltd
  • Phase 2
    AbGn-268
    Ulcerative Colitis AltruBio Inc
  • Marketed
    Abrysvo
    Abrysvo
    Respiratory Syncytial Virus (RSV) Infections$PFE PFIZER INC
  • Preclinical
    Ac-225 BisPSMA
    Prostate Cancer Clarity Pharmaceuticals Ltd
  • Phase 2
    Activated T Lymphocytes
    Hepatocellular Carcinoma Lukas Biomedical Inc
  • Marketed
    Acumin
    Topotecan Hydrochloride
    Small-Cell Lung Cancer$PFE PFIZER INC
  • Preclinical
    Acute Disseminated Encephalomyelitis
    Encephalomyelitis Trethera Corp
  • Phase 2
    AdAPT-001
    Chondrosarcoma EpicentRx Inc
  • Phase 2
    Adipose Tissue Derived Mesenchymal Stem Cells
    Coronavirus Disease 2019 (COVID-19) CellTex Therapeutics Corp
  • Discontinued
    Aduhelm
    Aduhelm (aducanumab)
    Alzheimer's disease (withdrawn from market 2024)$BIIB BIOGEN INC.
  • Preclinical
    Adze-1.17.C
    Glioblastoma Multiforme (GBM) Adze Biotechnology Inc
  • Preclinical
    AiSN Pancreatic Cancer
    Pancreatic Ductal Adenocarcinoma Theranostec Inc
  • Preclinical
    Alcoholic Liver Disease
    Alcohol Associated Liver Disease (ALD) GeneToBe LLC
  • Preclinical
    AlgiaPak
    Pain Algia Pharma LLC
  • Phase 2
    AlloStemspine
    olastrocel [INN]
    Chronic Low Back Pain (CLBP)$CELZ CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.